e-Drug3D
1225
MESORIDAZINE
DISCONTINUED
INN
MESORIDAZINE
cas 5588-33-0
CLASS
NERVOUS SYSTEM
ANTIPSYCHOTIC
DOPAMINE ANTAGONISTS
PHENOTHIAZINES
ROUTE (list)
ORAL INJECTION
ATC code
N05AC03
PK parameters
TARGET D(2) DOPAMINE RECEPTOR
5-HYDROXYTRYPTAMINE 2A RECEPTOR
D(2) dopamine receptor UNIPROT P14416 DRD2
5-hydroxytryptamine receptor 2A UNIPROT P28223 HTR2A
Formula:
C21H26N2OS2
Calculated chemical properties:
MW 386.58
NB_atoms 26
XLogP 4.90
PSA 25.115
NB_HD 0
NB_HA 3
fsp3 0.43
Lipinski(0=no;1=yes) 1
NB_atoms 26
XLogP 4.90
PSA 25.115
NB_HD 0
NB_HA 3
fsp3 0.43
Lipinski(0=no;1=yes) 1
FDA
NDA 016774 (pdf not found) INN (MESORIDAZINE BESYLATE) SERENTIL (NOVARTIS) APPROVAL= AP YEAR= 1970 DISCONTINUED
NDA 016775 (pdf not found) INN (MESORIDAZINE BESYLATE) SERENTIL (NOVARTIS) APPROVAL= AP YEAR= 1970 DISCONTINUED
NDA 016997 (pdf not found) INN (MESORIDAZINE BESYLATE) SERENTIL (NOVARTIS) APPROVAL= AP YEAR= 1972 DISCONTINUED
NDA 016774 (pdf not found) INN (MESORIDAZINE BESYLATE) SERENTIL (NOVARTIS) APPROVAL= AP YEAR= 1970 DISCONTINUED
NDA 016775 (pdf not found) INN (MESORIDAZINE BESYLATE) SERENTIL (NOVARTIS) APPROVAL= AP YEAR= 1970 DISCONTINUED
NDA 016997 (pdf not found) INN (MESORIDAZINE BESYLATE) SERENTIL (NOVARTIS) APPROVAL= AP YEAR= 1972 DISCONTINUED